 | • レポートコード：MRC23Q37476 • 出版社/出版日：QYResearch / 2023年3月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、87ページ • 納品方法：Eメール（2-3日） • 産業分類：医療機器 |
| Single User | ￥420,500 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥841,000 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のヘマトロジー制御市場について調査・分析し、世界のヘマトロジー制御市場概要、メーカー別競争状況、地域別市場規模、タイプ別セグメント分析（3液ヘマトロジー制御、5液ヘマトロジー制御、その他）、用途別セグメント分析（病院、研究所、その他）、主要企業のプロファイル、市場動向などに関する情報を掲載しています。主要企業としては、Sysmex、Danaher、Bio-Rad、Mindray、Abbott、Horiba、Boule、Diatronなどが含まれています。世界のヘマトロジー制御市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ヘマトロジー制御市場規模を推定する際に考慮しました。本レポートは、ヘマトロジー制御の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ヘマトロジー制御に関するビジネス上の意思決定に役立てることを目的としています。 ・ヘマトロジー制御市場の概要 - 製品の定義 - ヘマトロジー制御のタイプ別セグメント - 世界のヘマトロジー制御市場規模：タイプ別分析（3液ヘマトロジー制御、5液ヘマトロジー制御、その他） - ヘマトロジー制御の用途別セグメント - 世界のヘマトロジー制御市場規模：用途別分析（病院、研究所、その他） - 世界のヘマトロジー制御市場規模予測（2018年-2029年） - ヘマトロジー制御の平均価格推移（2018年-2029年） - 前提条件と制限事項 ・メーカー別競争状況 - メーカー別市場シェア - 世界の主要メーカー、業界ランキング分析 - メーカー別平均価格 - ヘマトロジー制御市場の競争状況およびトレンド ・ヘマトロジー制御の地域別市場規模 - 北米のヘマトロジー制御市場規模（2018年-2029年） - アメリカのヘマトロジー制御市場規模（2018年-2029年） - ヨーロッパのヘマトロジー制御市場規模（2018年-2029年） - アジア太平洋のヘマトロジー制御市場規模（2018年-2029年） - 中国のヘマトロジー制御市場規模（2018年-2029年） - 日本のヘマトロジー制御市場規模（2018年-2029年） - 韓国のヘマトロジー制御市場規模（2018年-2029年） - インドのヘマトロジー制御市場規模（2018年-2029年） - オーストラリアのヘマトロジー制御市場規模（2018年-2029年） - 中南米のヘマトロジー制御市場規模（2018年-2029年） - 中東・アフリカのヘマトロジー制御市場規模（2018年-2029年） ・タイプ別セグメント：3液ヘマトロジー制御、5液ヘマトロジー制御、その他 - 世界のヘマトロジー制御のタイプ別販売量（2018年-2023年） - 世界のヘマトロジー制御のタイプ別売上（2018年-2023年） - 世界のヘマトロジー制御のタイプ別価格 ・用途別セグメント：病院、研究所、その他 - 世界のヘマトロジー制御の用途別販売量（2018年-2023年） - 世界のヘマトロジー制御の用途別売上（2018年-2023年） - 世界のヘマトロジー制御の用途別価格 ・主要企業のプロファイル：企業情報、事業概要、売上、製品ポートフォリオ、動向 Sysmex、Danaher、Bio-Rad、Mindray、Abbott、Horiba、Boule、Diatron ・産業チェーンと販売チャネルの分析 - ヘマトロジー制御産業チェーン分析 - ヘマトロジー制御の主要原材料 - ヘマトロジー制御の販売チャネル - ヘマトロジー制御のディストリビューター - ヘマトロジー制御の主要顧客 ・ヘマトロジー制御市場ダイナミクス - ヘマトロジー制御の業界動向 - ヘマトロジー制御市場の成長ドライバ、課題、阻害要因 ・調査成果および結論 ・調査方法とデータソース |
Hematology controls are used to assess the precision of instruments such as hematology analyzers, thereby ensuring valid patient results and fulfilling accreditation requirements. The controls are commonly found in the clinical diagnostics laboratory.
Highlights
The global Hematology Controls market was valued at US$ 323.3 million in 2022 and is anticipated to reach US$ 518.6 million by 2029, witnessing a CAGR of 6.9% during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Global key players of Hematology Controls include Sysmex, Danaher, etc. Global top 3 companies hold a share about 70%. Asia Pacific is the largest market, with a share about 40%, followed by Europe and North America with the share about 25% and 20%. In terms of product, 3-Part is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospital, with a share over 60%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Hematology Controls, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hematology Controls.
The Hematology Controls market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Hematology Controls market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hematology Controls manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Sysmex
Danaher
Bio-Rad
Mindray
Abbott
Horiba
Boule
Diatron
Segment by Type
3-Part Hematology Controls
5-Part Hematology Controls
Others
Segment by Application
Hospital
Independent Lab
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hematology Controls manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hematology Controls in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Hematology Controls market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Reasons to Buy This Report
This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hematology Controls market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
This report will help stakeholders to understand the global industry status and trends of Hematology Controls and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
This report stays updated with novel technology integration, features, and the latest developments in the market
This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Hematology Controls industry.
This report helps stakeholders to gain insights into which regions to target globally
This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hematology Controls.
This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Hematology Controls manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Hematology Controls in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Analysis of sales channel, distributors and customers
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: sales and revenue forecast, global and regional, by Type and by Application. It provides a quantitative analysis of the market size and development potential of each market segment in the next six years.
Chapter 11: The main points and conclusions of the report.
1 Hematology Controls Market Overview
1.1 Product Overview and Scope of Hematology Controls
1.2 Hematology Controls Segment by Type
1.2.1 Global Hematology Controls Market Value Comparison by Type (2023-2029)
1.2.2 3-Part Hematology Controls
1.2.3 5-Part Hematology Controls
1.2.4 Others
1.3 Hematology Controls Segment by Application
1.3.1 Global Hematology Controls Market Value by Application: (2023-2029)
1.3.2 Hospital
1.3.3 Independent Lab
1.3.4 Others
1.4 Global Hematology Controls Market Size Estimates and Forecasts
1.4.1 Global Hematology Controls Revenue 2018-2029
1.4.2 Global Hematology Controls Sales 2018-2029
1.4.3 Global Hematology Controls Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Hematology Controls Market Competition by Manufacturers
2.1 Global Hematology Controls Sales Market Share by Manufacturers (2018-2023)
2.2 Global Hematology Controls Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Hematology Controls Average Price by Manufacturers (2018-2023)
2.4 Global Hematology Controls Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Hematology Controls, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hematology Controls, Product Type & Application
2.7 Hematology Controls Market Competitive Situation and Trends
2.7.1 Hematology Controls Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hematology Controls Players Market Share by Revenue
2.7.3 Global Hematology Controls Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hematology Controls Retrospective Market Scenario by Region
3.1 Global Hematology Controls Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Hematology Controls Global Hematology Controls Sales by Region: 2018-2029
3.2.1 Global Hematology Controls Sales by Region: 2018-2023
3.2.2 Global Hematology Controls Sales by Region: 2024-2029
3.3 Global Hematology Controls Global Hematology Controls Revenue by Region: 2018-2029
3.3.1 Global Hematology Controls Revenue by Region: 2018-2023
3.3.2 Global Hematology Controls Revenue by Region: 2024-2029
3.4 North America Hematology Controls Market Facts & Figures by Country
3.4.1 North America Hematology Controls Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Hematology Controls Sales by Country (2018-2029)
3.4.3 North America Hematology Controls Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Hematology Controls Market Facts & Figures by Country
3.5.1 Europe Hematology Controls Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Hematology Controls Sales by Country (2018-2029)
3.5.3 Europe Hematology Controls Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hematology Controls Market Facts & Figures by Country
3.6.1 Asia Pacific Hematology Controls Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Hematology Controls Sales by Country (2018-2029)
3.6.3 Asia Pacific Hematology Controls Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Hematology Controls Market Facts & Figures by Country
3.7.1 Latin America Hematology Controls Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Hematology Controls Sales by Country (2018-2029)
3.7.3 Latin America Hematology Controls Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Hematology Controls Market Facts & Figures by Country
3.8.1 Middle East and Africa Hematology Controls Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Hematology Controls Sales by Country (2018-2029)
3.8.3 Middle East and Africa Hematology Controls Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hematology Controls Sales by Type (2018-2029)
4.1.1 Global Hematology Controls Sales by Type (2018-2023)
4.1.2 Global Hematology Controls Sales by Type (2024-2029)
4.1.3 Global Hematology Controls Sales Market Share by Type (2018-2029)
4.2 Global Hematology Controls Revenue by Type (2018-2029)
4.2.1 Global Hematology Controls Revenue by Type (2018-2023)
4.2.2 Global Hematology Controls Revenue by Type (2024-2029)
4.2.3 Global Hematology Controls Revenue Market Share by Type (2018-2029)
4.3 Global Hematology Controls Price by Type (2018-2029)
5 Segment by Application
5.1 Global Hematology Controls Sales by Application (2018-2029)
5.1.1 Global Hematology Controls Sales by Application (2018-2023)
5.1.2 Global Hematology Controls Sales by Application (2024-2029)
5.1.3 Global Hematology Controls Sales Market Share by Application (2018-2029)
5.2 Global Hematology Controls Revenue by Application (2018-2029)
5.2.1 Global Hematology Controls Revenue by Application (2018-2023)
5.2.2 Global Hematology Controls Revenue by Application (2024-2029)
5.2.3 Global Hematology Controls Revenue Market Share by Application (2018-2029)
5.3 Global Hematology Controls Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Sysmex
6.1.1 Sysmex Corporation Information
6.1.2 Sysmex Description and Business Overview
6.1.3 Sysmex Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sysmex Hematology Controls Product Portfolio
6.1.5 Sysmex Recent Developments/Updates
6.2 Danaher
6.2.1 Danaher Corporation Information
6.2.2 Danaher Description and Business Overview
6.2.3 Danaher Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Danaher Hematology Controls Product Portfolio
6.2.5 Danaher Recent Developments/Updates
6.3 Bio-Rad
6.3.1 Bio-Rad Corporation Information
6.3.2 Bio-Rad Description and Business Overview
6.3.3 Bio-Rad Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Bio-Rad Hematology Controls Product Portfolio
6.3.5 Bio-Rad Recent Developments/Updates
6.4 Mindray
6.4.1 Mindray Corporation Information
6.4.2 Mindray Description and Business Overview
6.4.3 Mindray Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Mindray Hematology Controls Product Portfolio
6.4.5 Mindray Recent Developments/Updates
6.5 Abbott
6.5.1 Abbott Corporation Information
6.5.2 Abbott Description and Business Overview
6.5.3 Abbott Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Abbott Hematology Controls Product Portfolio
6.5.5 Abbott Recent Developments/Updates
6.6 Horiba
6.6.1 Horiba Corporation Information
6.6.2 Horiba Description and Business Overview
6.6.3 Horiba Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Horiba Hematology Controls Product Portfolio
6.6.5 Horiba Recent Developments/Updates
6.7 Boule
6.6.1 Boule Corporation Information
6.6.2 Boule Description and Business Overview
6.6.3 Boule Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Boule Hematology Controls Product Portfolio
6.7.5 Boule Recent Developments/Updates
6.8 Diatron
6.8.1 Diatron Corporation Information
6.8.2 Diatron Description and Business Overview
6.8.3 Diatron Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Diatron Hematology Controls Product Portfolio
6.8.5 Diatron Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hematology Controls Industry Chain Analysis
7.2 Hematology Controls Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hematology Controls Production Mode & Process
7.4 Hematology Controls Sales and Marketing
7.4.1 Hematology Controls Sales Channels
7.4.2 Hematology Controls Distributors
7.5 Hematology Controls Customers
8 Hematology Controls Market Dynamics
8.1 Hematology Controls Industry Trends
8.2 Hematology Controls Market Drivers
8.3 Hematology Controls Market Challenges
8.4 Hematology Controls Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
| 【ヘマトロジー制御について】 ヘマトロジー制御とは、血液に関連する検査や診断の精度を確保するためのプロセスや手法のことを指します。ヘマトロジー（Hematology）は血液の研究や治療に関わる領域であり、血液検査は多くの疾患の診断や治療効果のモニタリングにおいて重要な役割を果たしています。そのため、ヘマトロジー制御は医療や研究の現場で非常に重要な位置を占めています。 ヘマトロジー制御の定義は、血液に関連する検査の精度や信頼性を管理・向上させるための方法や制度を指します。具体的には、検査機器の校正、試料の適切な取り扱い、検査手順の標準化、人的エラーの最小化などが含まれます。これにより、正確で再現性のある結果を得ることが可能となり、医療従事者は適切な診断や治療計画を立てることができます。 ヘマトロジー制御の特徴としては、まずその高い精度が挙げられます。血液検査の結果は患者の健康状態を大きく左右するため、小さなエラーでも大きな影響を及ぼすことがあります。このため、厳格な制御が求められます。また、検査の迅速性も重要です。特に緊急の場合、迅速な結果が求められるため、ヘマトロジー制御は効率性とスピードの両立を図る必要があります。 ヘマトロジー制御にはいくつかの種類があります。まず、内部品質管理（Internal Quality Control, IQC）があります。これは、検査システムの内部で行われる品質管理のことで、定期的にパフォーマンスをチェックすることで、検査の精度を保つ役割を果たします。次に、外部品質評価（External Quality Assessment, EQA）があり、これは異なるラボや施設間での精度を比較評価するためのプロセスです。EQAは、検査結果の信頼性を評価するための客観的な指標となります。 さらに、これらのコントロールは、標準試料の使用によって補完されます。特定の成分や指標を持つ標準試料を用いることで、自ラボの結果が正確であるかを検証することができます。これにより、結果が標準範囲内に入っているかどうかを確認することができ、問題があれば早期に対処することが可能となります。 用途についても、多岐にわたります。主に病院や診療所で行われる血液検査において、ヘマトロジー制御は必要不可欠です。血液の成分分析、血液型の判定、感染症のスクリーニング、貧血の診断など、多くの検査項目に依存しています。また、研究機関においても、基礎研究や臨床研究において、データの信頼性が求められるため、ヘマトロジー制御の重要性は増しています。 関連する技術も様々です。自動化技術の進展によって、検査の精度とスピードが向上しました。自動血球計数器などの機器は、正確なデータを短時間で提供し、検査室の負担を軽減しています。また、データベースや情報管理システムの導入により、検査データの管理、解析、トレンド解析が加速され、全体的な効率性を向上させる役割を果たしています。 さらに、近年では分子生物学的技術も取り入れられています。PCR（ポリメラーゼ連鎖反応）技術を用いた遺伝子解析は、感染症の診断やがんの早期発見において重要な手法となっています。これにより、従来の血液検査だけでは得られなかった情報が得られ、より早期かつ正確な診断が可能となります。 このように、ヘマトロジー制御は医療現場において欠かせない要素であり、信頼性の高い血液検査を実現するための重要な基盤となっています。そのプロセスや技術は日々進化しており、新しい技術が導入されることで、より高精度な医療が提供されることが期待されています。将来的には、AI（人工知能）やビッグデータ解析の活用によって、さらに精度の高い予測や診断が可能になるでしょう。これにより、患者一人ひとりに最適な治療を提供することが可能となり、医療の質が向上することが期待されています。 ヘマトロジー制御は、医療の質を支える重要な基盤であり、今後もさらなる発展が期待される分野です。血液に関する知識や技術の向上は、医療従事者や研究者にとって不可欠であり、常に新しい情報を追求し続ける姿勢が求められます。各種の制御手法や技術を理解し、適切に運用することで、患者に対する最良の診断と治療を提供することが可能となります。ヘマトロジー制御の重要性を再認識し、より良い医療の実現に向けて努力が求められる時代に入っています。 |
